Alantis Sciences India Private Limited is funded by DBT-BIRAC for developing innovative smart technologies for advanced non-invasive diagnostic platforms for rapid, cost-effective, and point-of-care diagnostic products. Alantis Sciences is engaged in such an endeavour to develop rapid diagnostic tests for such human diseases as Malaria, Leptospirosis and Tuberculosis, developing suitable drugs for treatment using chemical entities, neutralizing antibodies as well as nucleic based therapeutics in the field of cervical, oral and breast cancers and developing multitargeting drugs for higher efficacy and specificity.

Health and social work

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.